Silver Spring, Maryland–(ENEWSPF)–April 1, 2015. The U.S. Food and Drug Administration today issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.
FDA Issues Final Guidance On the Evaluation and Labeling of Abuse-deterrent Opioids
More in Health and Fitness:
